Project milestone Open Access

Identifying new ligands for the SARS-CoV-2 Macrodomain by Fragment Screening and Multi-temperature Crystallography

James S Fraser

Research group(s)
QBI Coronavirus Research Group Structural Biology Consortium

Macrodomain is a compelling target for SARS-CoV-2, but there are no inhibitors (or even starting points for inhibitors). The QCRG Structural Biology Consortium performed a crystallographic fragments screen, identifying a few small molecules to kick-start our work to develop an inhibitor. Our friends in the UK, Ivan Ahel’s lab and X-Chem, did something similar and found even more fragment starting points. We are releasing the data together!

This record (see README file) has the data available here: and published here: 

Files (632.7 MB)
Name Size
1.6 MB Download
631.1 MB Download
All versions This version
Views 2,0911,150
Downloads 27246
Data volume 46.6 GB10.8 GB
Unique views 1,9121,055
Unique downloads 11937


Cite as